Partner, approval, merger, buyout. Any of these wo
Post# of 154612

But there's one more:
Stellar results in the mCRC with patients at 700 mg and a checkpoint inhibitor with no evidence of disease or greatly reduced disease for this type of cancer would be the equivalent of the
shot heard around the world.
Turning a cold tumor hot and having a truly effective treatment of LL and checkpoint inhibitor is really a big deal. More data needed to prove that, but it will come.
Hang in there.
Buying more, staying long, and keeping on keeping on

